REFERENCES
Adhikari, A., Lerner, T.N., Finkelstein, J., Pak, S., Jennings, J.H.,
Davidson, T.J., et al. (2015). Basomedial amygdala mediates top-down
control of anxiety and fear. Nature 527 : 179–185.
Alam, U., Sloan, G., and Tesfaye, S. (2020). Treating Pain in Diabetic
Neuropathy: Current and Developmental Drugs. Drugs 80 : 363–384.
Almeida, R.N., Navarro, D.S., and Barbosa-Filho, J.M. (2001). Plants
with central analgesic activity. Phytomedicine Int. J. Phytother.
Phytopharm. 8 : 310–322.
Baliki, M.N., and Apkarian, A.V. (2015). Nociception, Pain, Negative
Moods, and Behavior Selection. Neuron 87 : 474–491.
Campbell, J.N., and Meyer, R.A. (2006). Mechanisms of Neuropathic Pain.
Neuron 52 : 77–92.
Chen, C.-J., Zhong, Z.-F., Xin, Z.-M., Hong, L.-H., Su, Y.-P., and Yu,
C.-X. (2017). Koumine exhibits anxiolytic properties without inducing
adverse neurological effects on functional observation battery,
open-field and Vogel conflict tests in rodents. J. Nat. Med. 71 :
397–408.
Courteix, C., Eschalier, A., and Lavarenne, J. (1993).
Streptozocin-induced diabetic rats: behavioural evidence for a model of
chronic pain: Pain 53 : 81–88.
Curtis, M.J., Alexander, S., Cirino, G., Docherty, J.R., George, C.H.,
Giembycz, M.A., et al. (2018). Experimental design and analysis and
their reporting II: updated and simplified guidance for authors and peer
reviewers. Br. J. Pharmacol. 175 : 987–993.
Dauch, J.R., Yanik, B.M., Hsieh, W., Oh, S.S., and Cheng, H.T. (2012).
Neuron-astrocyte signaling network in spinal cord dorsal horn mediates
painful neuropathy of type 2 diabetes. Glia 60 : 1301–1315.
De Gregorio, D., McLaughlin, R.J., Posa, L., Ochoa-Sanchez, R., Enns,
J., Lopez-Canul, M., et al. (2019). Cannabidiol modulates serotonergic
transmission and reverses both allodynia and anxiety-like behavior in a
model of neuropathic pain. Pain 160 : 136–150.
Donnelly, C.R., Andriessen, A.S., Chen, G., Wang, K., Jiang, C.,
Maixner, W., et al. (2020). Central Nervous System Targets: Glial Cell
Mechanisms in Chronic Pain. Neurother. J. Am. Soc. Exp. Neurother.17 : 846–860.
Feldman EL, Callaghan BC, and Pop-Busui R (2019). Diabetic neuropathy.
Nat. Rev. Dis. Primer 5 : 42.
Finnerup, N.B., Kuner, R., and Jensen, T.S. (2021). Neuropathic Pain:
From Mechanisms to Treatment. Physiol. Rev. 101 : 259–301.
Fox, A., Eastwood, C., Gentry, C., Manning, D., and Urban, L. (1999).
Critical evaluation of the streptozotocin model of painful diabetic
neuropathy in the rat: Pain 81 : 307–316.
Grace, P.M., Strand, K.A., Galer, E.L., Urban, D.J., Wang, X., Baratta,
M.V., et al. (2016). Morphine paradoxically prolongs neuropathic pain in
rats by amplifying spinal NLRP3 inflammasome activation. Proc. Natl.
Acad. Sci. 113 : E3441–E3450.
Griffin, J.M., Fackelmeier, B., Fong, D.M., Mouravlev, A., Young, D.,
and O’Carroll, S.J. (2019). Astrocyte-selective AAV gene therapy through
the endogenous GFAP promoter results in robust transduction in the rat
spinal cord following injury. Gene Ther. 26 : 198–210.
Hartley, N.D., Gaulden, A.D., Báldi, R., Winters, N.D., Salimando, G.J.,
Rosas-Vidal, L.E., et al. (2019). Dynamic remodeling of a
basolateral-to-central amygdala glutamatergic circuit across fear
states. Nat. Neurosci. 22 : 2000–2012.
Hua, T., Chen, B., Lu, D., Sakurai, K., Zhao, S., Han, B.-X., et al.
(2020). General anesthetics activate a potent central pain-suppression
circuit in the amygdala. Nat. Neurosci. 23 : 854–868.
Hung, A.L., Lim, M., and Doshi, T.L. (2017). Targeting cytokines for
treatment of neuropathic pain. Scand. J. Pain 17 : 287–293.
Ji, R.-R., Donnelly, C.R., and Nedergaard, M. (2019). Astrocytes in
chronic pain and itch. Nat. Rev. Neurosci. 20 : 667–685.
Ji, R.-R., Xu, Z.-Z., and Gao, Y.-J. (2014). Emerging targets in
neuroinflammation-driven chronic pain. Nat. Rev. Drug Discov. 13 :
533–548.
Jiang, Y., Wang, J., Li, H., and Xia, L. (2019). IL-35 alleviates
inflammation progression in a rat model of diabetic neuropathic pain via
inhibition of JNK signaling. J. Inflamm. 16 : 19.
Jin, G.-L., He, S.-D., Lin, S.-M., Hong, L.-M., Chen, W.-Q., Xu, Y., et
al. (2018). Koumine Attenuates Neuroglia Activation and Inflammatory
Response to Neuropathic Pain. Neural Plast. 2018 : 1–13.
Jin, G.-L., Hong, L.-M., Liu, H.-P., Yue, R.-C., Shen, Z.-C., Yang, J.,
et al. (2021). Koumine modulates spinal microglial M1 polarization and
the inflammatory response through the Notch-RBP-Jκ signaling pathway,
ameliorating diabetic neuropathic pain in rats. Phytomedicine Int. J.
Phytother. Phytopharm. 90 : 153640.
Kang, J.W.M., Mor, D., and Keay, K.A. (2021). Nerve injury alters
restraint-induced activation of the basolateral amygdala in male rats.
Brain Struct. Funct.
Lee, H.-M., Giguere, P.M., and Roth, B.L. (2014). DREADDs: novel tools
for drug discovery and development. Drug Discov. Today 19 :
469–473.
Li, T., Chen, X., Zhang, C., Zhang, Y., and Yao, W. (2019). An update on
reactive astrocytes in chronic pain. J. Neuroinflammation 16 :
140.
Li, Z., Wang, J., Chen, L., Zhang, M., and Wan, Y. (2013). Basolateral
Amygdala Lesion Inhibits the Development of Pain Chronicity in
Neuropathic Pain Rats. PLoS ONE 8 : e70921.
Liao, Y.-H., Zhang, G.-H., Jia, D., Wang, P., Qian, N.-S., He, F., et
al. (2011). Spinal astrocytic activation contributes to mechanical
allodynia in a mouse model of type 2 diabetes. Brain Res. 1368 :
324–335.
Lilley, E., Stanford, S.C., Kendall, D.E., Alexander, S.P.H., Cirino,
G., Docherty, J.R., et al. (2020). ARRIVE 2.0 and the British Journal of
Pharmacology: Updated guidance for 2020. Br. J. Pharmacol. 177 :
3611–3616.
Linnerbauer, M., Wheeler, M.A., and Quintana, F.J. (2020). Astrocyte
Crosstalk in CNS Inflammation. Neuron 108 : 608–622.
Liu, M., Huang, H.-H., Yang, J., Su, Y.-P., Lin, H.-W., Lin, L.-Q., et
al. (2013). The active alkaloids of Gelsemium elegans Benth. are potent
anxiolytics. Psychopharmacology (Berl.) 225 : 839–851.
Lu, J., Yang, L., Xu, Y., Ai, L., Chen, J., Xiong, F., et al. (2021).
The Modulatory Effect of Motor Cortex Astrocytes on Diabetic Neuropathic
Pain. J. Neurosci. 41 : 5287–5302.
Marcello, L., Cavaliere, C., Colangelo, A.M., Bianco, M.R., Cirillo, G.,
Alberghina, L., et al. (2013). Remodelling of supraspinal neuroglial
network in neuropathic pain is featured by a reactive gliosis of the
nociceptive amygdala: Supraspinal plasticity following neuropathic pain.
Eur. J. Pain 17 : 799–810.
Moraes, T.R., Elisei, L.S., Malta, I.H., and Galdino, G. (2020).
Participation of CXCL1 in the glial cells during neuropathic pain. Eur.
J. Pharmacol. 875 : 173039.
Nakagawa, T., and Kaneko, S. (2010). Spinal astrocytes as therapeutic
targets for pathological pain. J. Pharmacol. Sci. 114 : 347–353.
Peltier, A., Goutman, S.A., and Callaghan, B.C. (2014). Painful diabetic
neuropathy. BMJ 348 : g1799–g1799.
Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M.T.,
Baker, M., et al. (2020). The ARRIVE guidelines 2.0: Updated guidelines
for reporting animal research. PLoS Biol. 18 : e3000410.
Pickering, C.A., and Mazarakis, N.D. (2021). Viral Vector Delivery of
DREADDs for CNS Therapy. Curr. Gene Ther. 21 : 191–206.
Rosenberger, D.C., Blechschmidt, V., Timmerman, H., Wolff, A., and
Treede, R.-D. (2020). Challenges of neuropathic pain: focus on diabetic
neuropathy. J. Neural Transm. 127 : 589–624.
Roth, B.L. (2016). DREADDs for Neuroscientists. Neuron 89 :
683–694.
Sagalajev, B., Wei, H., Chen, Z., Albayrak, I., Koivisto, A., and
Pertovaara, A. (2018). Oxidative Stress in the Amygdala Contributes to
Neuropathic Pain. Neuroscience 387 : 92–103.
Sah, P. (2017). Fear, Anxiety, and the Amygdala. Neuron 96 : 1–2.
Schnedl, W.J., Ferber, S., Johnson, J.H., and Newgard, C.B. (1994). STZ
transport and cytotoxicity. Specific enhancement in GLUT2-expressing
cells. Diabetes 43 : 1326–1333.
Shen, W., Chen, S., Liu, Y., Han, P., Ma, T., and Zeng, L.-H. (2021).
Chemogenetic manipulation of astrocytic activity: Is it possible to
reveal the roles of astrocytes? Biochem. Pharmacol. 186 : 114457.
Shoaib, R.M., Zhang, J.-Y., Mao, X.-F., and Wang, Y.-X. (2019).
Gelsemine and koumine, principal active ingredients of Gelsemium,
exhibit mechanical antiallodynia via spinal glycine receptor
activation-induced allopregnanolone biosynthesis. Biochem. Pharmacol.161 : 136–148.
Sommer, C., Leinders, M., and Üçeyler, N. (2018). Inflammation in the
pathophysiology of neuropathic pain. Pain 159 : 595–602.
Su, Y.-P., Shen, J., Xu, Y., Zheng, M., and Yu, C.-X. (2011).
Preparative separation of alkaloids from Gelsemium elegans Benth. using
pH-zone-refining counter-current chromatography. J. Chromatogr. A1218 : 3695–3698.
Sun, L., Liu, R., Guo, F., Wen, M.-Q., Ma, X.-L., Li, K.-Y., et al.
(2020). Parabrachial nucleus circuit governs neuropathic pain-like
behavior. Nat. Commun. 11 : 5974.
Sun, T., Song, Z., Tian, Y., Tian, W., Zhu, C., Ji, G., et al. (2019).
Basolateral amygdala input to the medial prefrontal cortex controls
obsessive-compulsive disorder-like checking behavior. Proc. Natl. Acad.
Sci. U. S. A. 116 : 3799–3804.
Tang, J., Bair, M., and Descalzi, G. (2021). Reactive Astrocytes:
Critical Players in the Development of Chronic Pain. Front. Psychiatry12 : 682056.
Taschenberger, G., Tereshchenko, J., and Kügler, S. (2017). A
MicroRNA124 Target Sequence Restores Astrocyte Specificity of
gfaABC1D-Driven Transgene Expression in AAV-Mediated Gene Transfer. Mol.
Ther. Nucleic Acids 8 : 13–25.
Thompson, J.M., and Neugebauer, V. (2017). Amygdala Plasticity and Pain.
Pain Res. Manag. 2017 : 8296501.
Xiao, Q., Xu, X., and Tu, J. (2020). Chronic optogenetic manipulation of
basolateral amygdala astrocytes rescues stress-induced anxiety. Biochem.
Biophys. Res. Commun. 533 : 657–664.
Xiong, B.-J., Xu, Y., Jin, G.-L., Liu, M., Yang, J., and Yu, C.-X.
(2017). Analgesic effects and pharmacologic mechanisms of the Gelsemium
alkaloid koumine on a rat model of postoperative pain. Sci. Rep.7 : 14269.
Xu, Y., Qiu, H.-Q., Liu, H., Liu, M., Huang, Z.-Y., Yang, J., et al.
(2012). Effects of koumine, an alkaloid of Gelsemium elegans Benth., on
inflammatory and neuropathic pain models and possible mechanism with
allopregnanolone. Pharmacol. Biochem. Behav. 101 : 504–514.
Zamyad, M., Abbasnejad, M., Esmaeili-Mahani, S., Sheibani, V., and
Raoof, M. (2021). Pain influences food preference and food-related
memory by activating the basolateral amygdala in rats. Exp. Brain Res.239 : 79–93.
Zhang, J.-Y., and Wang, Y.-X. (2015). Gelsemium analgesia and the spinal
glycine receptor/allopregnanolone pathway. Fitoterapia 100 :
35–43.
Zhang, Z.-J., Jiang, B.-C., and Gao, Y.-J. (2017). Chemokines in
neuron–glial cell interaction and pathogenesis of neuropathic pain.
Cell. Mol. Life Sci. 74 : 3275–3291.
Zuo, Z.-F., Liao, Y.-H., Ding, T., Dong, Y.-L., Qu, J., Wang, J., et al.
(2015). Astrocytic NDRG2 is involved in glucocorticoid-mediated diabetic
mechanical allodynia. Diabetes Res. Clin. Pract. 108 : 128–136.